AGER and colon adenocarcinoma: To the best of our knowledge this is the first study demonstrating that S100B has a direct-pro-angiogenic effect acting in vitro as a direct neovascularization promoter by the activation of a RAGE-dependent pAkt/mTOR pathway in a human colon adenocarcinoma cell line.